Sweden · Delayed Price · Currency is SEK Ascelia Pharma AB Statistics
Total Valuation
STO:ACE has a market cap or net worth of SEK 543.58 million. The enterprise value is 491.34 million.
| Market Cap | 543.58M |
| Enterprise Value | 491.34M |
Important Dates
The last earnings date was Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ACE has 116.03 million shares outstanding. The number of shares has increased by 164.11% in one year.
| Current Share Class | 116.03M |
| Shares Outstanding | 116.03M |
| Shares Change (YoY) | +164.11% |
| Shares Change (QoQ) | +17.54% |
| Owned by Insiders (%) | 6.91% |
| Owned by Institutions (%) | 21.68% |
| Float | 104.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.80 |
| P/TBV Ratio | 14.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.18 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.94 |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.15 |
| Quick Ratio | 2.07 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -16.52 |
Financial Efficiency
Return on equity (ROE) is -134.06% and return on invested capital (ROIC) is -56.61%.
| Return on Equity (ROE) | -134.06% |
| Return on Assets (ROA) | -47.20% |
| Return on Invested Capital (ROIC) | -56.61% |
| Return on Capital Employed (ROCE) | -88.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -8.62M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -416,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +108.85% in the last 52 weeks. The beta is 1.03, so STO:ACE's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +108.85% |
| 50-Day Moving Average | 4.59 |
| 200-Day Moving Average | 3.55 |
| Relative Strength Index (RSI) | 48.81 |
| Average Volume (20 Days) | 962,521 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -83.18M |
| Pretax Income | -95.20M |
| Net Income | -94.78M |
| EBITDA | -83.10M |
| EBIT | -83.18M |
| Earnings Per Share (EPS) | -1.06 |
Balance Sheet
The company has 60.44 million in cash and 8.21 million in debt, giving a net cash position of 52.24 million or 0.45 per share.
| Cash & Cash Equivalents | 60.44M |
| Total Debt | 8.21M |
| Net Cash | 52.24M |
| Net Cash Per Share | 0.45 |
| Equity (Book Value) | 93.71M |
| Book Value Per Share | 0.83 |
| Working Capital | 35.87M |
Cash Flow
In the last 12 months, operating cash flow was -70.73 million and capital expenditures -57,000, giving a free cash flow of -70.79 million.
| Operating Cash Flow | -70.73M |
| Capital Expenditures | -57,000 |
| Free Cash Flow | -70.79M |
| FCF Per Share | -0.61 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:ACE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -164.11% |
| Shareholder Yield | n/a |
| Earnings Yield | -17.44% |
| FCF Yield | -13.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |